Article
First-, Second-, and Third-Generation Radiolabeled Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Positron Emission Tomography: State of the Art, a Systematic Review.
Cancer biotherapy & radiopharmaceuticals - 1 May 2023
Sidrak Marko Magdi Abdou, De Feo Maria Silvia, Frantellizzi Viviana, Marongiu Andrea, Caponnetto Salvatore, Filippi Luca, Nuvoli Susanna, Spanu Angela, Schillaci Orazio, De Vincentis Giuseppe
Abstract excerpt
Introduction: Lung cancer (LC) is a leading cause of death among men and women, with non-small cell LC (NSCLC) accounting for a substantial portion of the histopathological spectrum and epidermal growth factor receptor (EGFR) mutations being correlated with its manifestation and evolution. Positron emission tomography (PET)/computed tomography has been the most widely used instrument to assess and monitor LC in a...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
